Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MirGeneDB 3.0: improved taxonomic sampling, uniform nomenclature of novel conserved microRNA families and updated covariance models.
Clarke AW, Høye E, Hembrom AA, Paynter VM, Vinther J, Wyrożemski Ł, Biryukova I, Formaggioni A, Ovchinnikov V, Herlyn H, Pierce A, Wu C, Aslanzadeh M, Cheneby J, Martinez P, Friedländer MR, Hovig E, Hackenberg M, Umu SU, Johansen M, Peterson KJ, Fromm B. Clarke AW, et al. Among authors: friedlander mr. Nucleic Acids Res. 2024 Nov 30:gkae1094. doi: 10.1093/nar/gkae1094. Online ahead of print. Nucleic Acids Res. 2024. PMID: 39673268
Development of an Open-Source Dataset of Flat-Mounted Images for the Murine Oxygen-Induced Retinopathy Model of Ischemic Retinopathy.
Marra KV, Chen JS, Robles-Holmes HK, Ly KB, Miller J, Wei G, Aguilar E, Bucher F, Ideguchi Y, Kalaw FGP, Lin AC, Ferrara N, Campbell JP, Friedlander M, Nudleman E. Marra KV, et al. Among authors: friedlander m. Transl Vis Sci Technol. 2024 Dec 2;13(12):4. doi: 10.1167/tvst.13.12.4. Transl Vis Sci Technol. 2024. PMID: 39625436 Free PMC article.
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.
Marth C, Moore RG, Bidziński M, Pignata S, Ayhan A, Rubio MJ, Beiner M, Hall M, Vulsteke C, Braicu EI, Sonoda K, Wu X, Frentzas S, Mattar A, Lheureux S, Chen X, Hasegawa K, Magallanes-Maciel M, Choi CH, Shalkova M, Kaen D, Wang PH, Berger R, Okpara CE, McKenzie J, Yao L, Orlowski R, Khemka V, Gilbert L, Makker V; ENGOT-en9/LEAP-001 Investigators. Marth C, et al. J Clin Oncol. 2024 Nov 26:JCO2401326. doi: 10.1200/JCO-24-01326. Online ahead of print. J Clin Oncol. 2024. PMID: 39591551
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.
Francis KE, Simon S, Gebski V, Joly F, Ledermann JA, Penson RT, Oza AM, Korach J, Lainez N, Cecere SC, Tasca G, Gropp-Meier M, Fujiwara K, Lowe ES, Friedlander M, Pujade-Lauraine E, Lee CK. Francis KE, et al. Among authors: friedlander m. Gynecol Oncol. 2024 Nov 12;192:50-55. doi: 10.1016/j.ygyno.2024.11.004. Online ahead of print. Gynecol Oncol. 2024. PMID: 39536691 Free article.
The end of an entire biome? World's largest wetland, the Pantanal, is menaced by the Hidrovia project which is uncertain to sustainably support large-scale navigation.
Wantzen KM, Assine ML, Bortolotto IM, Calheiros DF, Campos Z, Catella AC, Chiaravalotti RM, Collischonn W, Couto EG, da Cunha CN, Damasceno-Junior GA, da Silva CJ, Eberhard A, Ebert A, de Figueiredo DM, Friedlander M, Garcia LC, Girard P, Hamilton SK, Ikeda-Castrillon S, Libonati R, Lourival R, de Azevedo Macedo H, Junior JM, Mateus L, Morato RG, Mourão G, Muniz CC, Nunes AV, de Oliveira MD, da Rosa Oliveria M, Junior ESO, Padovani CR, Penha J, Ribeiro DB, de Oliveira Roque F, Silva A, Soriano BMA, de Sousa Junior WC, Tomas WM, Tortato FR, Urbanetz C. Wantzen KM, et al. Among authors: friedlander m. Sci Total Environ. 2023 Oct 28:167751. doi: 10.1016/j.scitotenv.2023.167751. Online ahead of print. Sci Total Environ. 2023. PMID: 39492524
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomes.
Haggstrom L, Lee YC, Scott C, Harter P, Woelber L, Ledermann J, Gourley C, McNeish IA, Amant F, Ray-Coquard I, Leary A, Oza AM, Tinker A, González Martin A, Cecere SC, Pignata S, Colombo N, Yoshida H, Marth C, Rosengarten O, Moore KN, Gómez-García EM, Tan D, Friedlander ML. Haggstrom L, et al. Among authors: friedlander ml. Int J Gynecol Cancer. 2024 Dec 2;34(12):1932-1939. doi: 10.1136/ijgc-2024-005976. Int J Gynecol Cancer. 2024. PMID: 39438068
1,100 results